7Baggers
Quarterly
Annual
    Unit: USD2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31 
      
    		     
      first nine months
    		     
      cash flows from operating activities
    		     
      net income/
    		1,831,000,000 -523,000,000 1,259,000,000 12,273,000,000 -2,791,000,000 
      depreciation and tooling amortization
    		1,931,000,000 2,012,000,000 1,973,000,000 1,840,000,000 2,081,000,000 
      other amortization
    		-481,000,000 -314,000,000 -273,000,000 -324,000,000 -356,000,000 
      benefit from credit and insurance losses
    		142,000,000    63,000,000 
      pension and other postretirement employee benefits
    		-540,000,000 2,026,000,000    
      equity method investment (earnings)/losses and impairments in excess of dividends received
    		     
      foreign currency adjustments
    		-69,000,000 -135,000,000 44,000,000 184,000,000 -204,000,000 
      net realized and unrealized
    		17,000,000 18,000,000 153,000,000   
      stock compensation
    		107,000,000 110,000,000 59,000,000 43,000,000 29,000,000 
      benefit from/(benefit from) deferred income taxes
    		679,000,000 -1,604,000,000    
      decrease/
    		-1,560,000,000 -3,593,000,000 -3,959,000,000 -852,000,000 1,098,000,000 
      decrease/(increase) in accounts receivable and other assets
    		-451,000,000 345,000,000 1,187,000,000 188,000,000 -137,000,000 
      decrease/(increase) in inventory
    		2,365,000,000 3,010,000,000 1,584,000,000 1,351,000,000 350,000,000 
      increase/(decrease) in accounts payable and accrued and other liabilities
    		-961,000,000 634,000,000 -1,185,000,000 475,000,000 2,951,000,000 
      other
    		89,000,000 369,000,000 79,000,000 -158,000,000 25,000,000 
      net cash provided by/(used in) operating activities
    		3,028,000,000 2,492,000,000 1,178,000,000 3,531,000,000 4,539,000,000 
      cash flows from investing activities
    		     
      capital spending
    		-2,498,000,000 -2,295,000,000 -2,065,000,000 -1,772,000,000 -1,531,000,000 
      acquisitions of finance receivables and operating leases
    		-14,778,000,000 -14,343,000,000 -12,545,000,000 -13,686,000,000 -12,428,000,000 
      collections of finance receivables and operating leases
    		11,304,000,000 10,835,000,000 10,600,000,000 12,654,000,000 12,210,000,000 
      purchases of marketable securities and other investments
    		-3,799,000,000 -2,691,000,000 -3,343,000,000 -4,248,000,000 -12,223,000,000 
      sales and maturities of marketable securities and other investments
    		1,735,000,000 2,316,000,000 2,909,000,000 4,790,000,000 7,993,000,000 
      settlements of derivatives
    		-94,000,000 69,000,000 -139,000,000 -28,000,000 84,000,000 
      capital contributions to equity method investments
    		-123,000,000 -1,118,000,000    
      returns of capital from equity method investments
    		     
      net cash provided by/(used in) investing activities
    		-6,861,000,000 -7,409,000,000 -4,972,000,000 -2,263,000,000 -5,745,000,000 
      cash flows from financing activities
    		     
      cash payments for dividends and dividend equivalents
    		-596,000,000 -601,000,000 -599,000,000 -400,000,000 0 
      purchases of common stock
    		-150,000,000     
      net changes in short-term debt
    		957,000,000 -597,000,000 3,810,000,000 1,705,000,000 524,000,000 
      proceeds from issuance of long-term debt
    		13,733,000,000 15,077,000,000 12,615,000,000 8,601,000,000 11,575,000,000 
      payments of long-term debt
    		-10,117,000,000 -10,146,000,000 -8,260,000,000   
      net cash provided by/(used in) financing activities
    		3,790,000,000 3,383,000,000 7,055,000,000 -8,078,000,000 2,284,000,000 
      effect of exchange rate changes on cash, cash equivalents, and restricted cash
    		-493,000,000 10,000,000 358,000,000 -77,000,000 385,000,000 
      net increase/(decrease) in cash, cash equivalents, and restricted cash
    		-536,000,000 -1,524,000,000 3,619,000,000 -6,887,000,000 1,463,000,000 
      cash, cash equivalents, and restricted cash at beginning of period
    		0 0 0 0 0 
      cash, cash equivalents, and restricted cash at end of period
    		-536,000,000 -1,524,000,000 3,619,000,000 -6,887,000,000 1,463,000,000 
      first half
    		     
      first quarter
    		     
      proceeds from sale of business
    		  14,000,000 0 0 
      equity method investment dividends received in excess of (earnings)/losses and impairments
    		 38,000,000    
      1,702
    		     
      benefit from/(benefit from) credit and insurance losses
    		 89,000,000 116,000,000   
      net
    		 10,000,000 10,000,000 -14,000,000  
      121
    		     
      held-for-sale impairment charges
    		    2,000,000 
      brazil manufacturing exit non-cash charges
    		     
      1
    		     
      benefit from deferred income taxes
    		   -1,215,000,000 -1,247,000,000 
      8
    		     
      held for sale impairment charges
    		     
      pension and other post-retirement employee benefits
    		    1,481,000,000 
      equity method investment dividends received in excess of
    		     
      55
    		     
      equity investment dividends received in excess of (earnings)/losses
    		   21,000,000 -2,000,000 
      net realized and unrealized (gains)/losses on cash equivalents, marketable securities, and other investments
    		     
      increase/(decrease) in benefit from credit and insurance losses
    		     
      net unrealized
    		     
      principal payments on long-term debt
    		    -9,873,000,000 
      net (gain)/loss on changes in investments in affiliates
    		     
      net income
    		     
      equity investment (earnings)/losses in excess of dividends received
    		     
      purchases of marketable and other securities
    		     
      sales and maturities of marketable and other securities
    		     
      cash, cash equivalents, and restricted cash at january 1
    		     
      cash, cash equivalents, and restricted cash at march 31
    		     
      cash dividends
    		     
      cash, cash equivalents, and restricted cash at september 30
    		     
      cash, cash equivalents, and restricted cash at june 30
    		     
      purchases of equity and debt securities
    		     
      sales and maturities of equity and debt securities
    		     
      proceeds from issuance of other debt
    		     
      principal payments on other debt
    		     
      effect of exchange rate changes on cash and cash equivalents
    		     
      net increase/(decrease) in cash and cash equivalents
    		     
      cash and cash equivalents at january 1
    		     
      cash and cash equivalents at march 31
    		     
      cash flows from operating activities of continuing operations
    		     
      cash flows from investing activities of continuing operations
    		     
      capital expenditures
    		     
      acquisitions of retail and other finance receivables and operating leases
    		     
      collections of retail and other finance receivables and operating leases
    		     
      purchases of securities
    		     
      sales and maturities of securities
    		     
      cash flows from financing activities of continuing operations
    		     
      changes in short-term debt
    		     
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.